Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Navigating Psychedelics for Clinicians and Therapists Course: Informational Meeting with Joe...

PT251 – Kristina & Jonas of the Psychedelic Literacy Fund –...

Harvard Law School’s Petrie-Flom Center Launches Research Initiative on Psychedelics and...

Psyched Wellness Announces Matthew Singh Joins Team as CPG and Branding...

Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana

What Is Transpersonal Psychology and How Does It Relate to Psychedelics?

Comparing Psilocybin Mushroom Bruising with Trichoderma Infection

PT250 – Matt Ball – New Frameworks For Schizophrenia, Dissociation, and...

Cybin Announces Positive Pre-Clinical Results With Multiple Proprietary Psychedelic Molecules and...

COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in...

1...204205206...218 Page 205 of 218

EDITOR PICKS

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in...

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

Opinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin